Rob Woodman is a Partner at Panakes, where they have been involved since 2021. Previously, Rob held several Non Executive Director positions at various biotechnology companies including STORM Therapeutics Limited, Crescendo Biologics Limited, and Obsidian Therapeutics. They served as Senior Partner and Head of Genesis Labs at Takeda Ventures from 2018 to 2021. Rob has an extensive background in healthcare ventures, having worked with firms such as Imperial Innovations and Touchstone Innovations. They completed a PhD in Oncology and Cancer Biology at the University of Cambridge and an MSc in Biochemistry and Molecular Biology at the University of Oxford.
Location
Cambridge, United Kingdom